SWTX — SpringWorks Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00
- $3.34bn
- $2.86bn
- $5.45m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -58.3 | -45.6 | -174 | -277 | -325 |
Depreciation | |||||
Non-Cash Items | 5.72 | 11.7 | 40.4 | 77 | 101 |
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 4.95 | 1.35 | 5.12 | 38.1 | -0.583 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -47.4 | -32.2 | -128 | -162 | -223 |
Capital Expenditures | -0.67 | -0.642 | -2.02 | -10.2 | -7.38 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -3.59 | -418 | 85.6 | -205 | 42.1 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -4.26 | -419 | 83.6 | -216 | 34.8 |
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 334 | 270 | 1.16 | 341 | 297 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 282 | -181 | -43.1 | -36.5 | 109 |